Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments
Scott, Stacey J.
Cell Death & Differentiation
Nature Publishing Group UK
MetadataShow full item record
Scott, S. J., Li, X., Jammula, S., Devonshire, G., Lindon, C., Fitzgerald, R. C., & D’Avino, P. P. (2021). Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments. Cell Death & Differentiation, 28 (7), 2179-2193. https://doi.org/10.1038/s41418-021-00745-8
Abstract: Polyploidy is present in many cancer types and is increasingly recognized as an important factor in promoting chromosomal instability, genome evolution, and heterogeneity in cancer cells. However, the mechanisms that trigger polyploidy in cancer cells are largely unknown. In this study, we investigated the origin of polyploidy in esophageal adenocarcinoma (EAC), a highly heterogenous cancer, using a combination of genomics and cell biology approaches in EAC cell lines, organoids, and tumors. We found the EAC cells and organoids present specific mitotic defects consistent with problems in the attachment of chromosomes to the microtubules of the mitotic spindle. Time-lapse analyses confirmed that EAC cells have problems in congressing and aligning their chromosomes, which can ultimately culminate in mitotic slippage and polyploidy. Furthermore, whole-genome sequencing, RNA-seq, and quantitative immunofluorescence analyses revealed alterations in the copy number, expression, and cellular distribution of several proteins known to be involved in the mechanics and regulation of chromosome dynamics during mitosis. Together, these results provide evidence that an imbalance in the amount of proteins implicated in the attachment of chromosomes to spindle microtubules is the molecular mechanism underlying mitotic slippage in EAC. Our findings that the likely origin of polyploidy in EAC is mitotic failure caused by problems in chromosomal attachments not only improves our understanding of cancer evolution and diversification, but may also aid in the classification and treatment of EAC and possibly other highly heterogeneous cancers.
Article, /631/67, /631/80, /14, /14/19, /14/63, /45/91, /45/23, article
RCUK | MRC | Medical Research Foundation (RG84369)
Cancer Research UK (CRUK) (RG81771/84119)
External DOI: https://doi.org/10.1038/s41418-021-00745-8
This record's URL: https://www.repository.cam.ac.uk/handle/1810/324896